Clinical Evaluation of 2-Week Reusable ACUVUE 2 Vivid Style

Johnson & Johnson (J&J) logo

Johnson & Johnson (J&J)

Status

Completed

Conditions

Visual Acuity

Treatments

Device: JJVC Marketed Contact Lens

Study type

Interventional

Funder types

Industry

Identifiers

NCT03431441
CR-6180

Details and patient eligibility

About

This will be a single site, non-randomized, dispensing, brand-masked to the subject, bilateral single treatment study. There will be 2 study visits with a 10 to 14-day contact lens wear period between visits.

Enrollment

26 patients

Sex

Female

Ages

18 to 39 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

-Potential subjects must satisfy all of the following criteria to be enrolled in the study:

  • The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
  • Appear able and willing to adhere to the instructions set forth in this clinical protocol (i.e., willing to wear only the study lenses and not use habitual lenses during the study).
  • Females between 18 and 39 (inclusive) years of age at the time of screening.
  • The subject's vertex corrected spherical equivalent distance refraction must be in the range of -1.00 D to -6.00 D (inclusive) in each eye.
  • The subject's refractive cylinder must be less than or equal to 0.75 D (inclusive) in each eye.
  • Have spherical best corrected visual acuity of 20/30 or better in each eye.
  • Be a current soft contact lens wearer in both eyes with a minimum of 6 hours/day and 5 days/week over the last month by self-report.
  • The subject must be willing to be photographed and/or video-taped.

Exclusion criteria

  • Currently pregnant or lactating
  • Any systemic disease (eg, Sjögren's Syndrome), allergies, infectious disease (eg, hepatitis, tuberculosis), contagious immunosuppressive diseases (eg, HIV), autoimmune disease (eg rheumatoid arthritis), or other diseases, by self-report, which are known to interfere with contact lens wear and/or participation in the study (at the investigators discretion).
  • Use of systemic medications (eg, chronic steroid use) that are known to interfere with contact lens wear (at the investigators discretion).
  • Any previous, or planned (during the study) ocular surgery (eg, radial keratotomy, PRK, LASIK, etc.).
  • Any previous history or signs of a contact lens-related corneal inflammatory event (eg, past peripheral ulcer or round peripheral scar), or any other ocular abnormality that would contraindicate contact lens wear.
  • Participation in any contact lens or lens care product clinical trial within seven (7) days prior to study enrollment.
  • Employee or family members of clinical site (eg, Investigator, Coordinator, Technician).

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

26 participants in 1 patient group

JJVC Marketed Contact Lens
Experimental group
Description:
ACUVUE 2 Vivid Style
Treatment:
Device: JJVC Marketed Contact Lens

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems